Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

1.140

-0.020 (-1.72%)

At close: Nov 13, 2026, 4:00 PM EST

1.160

+0.020 (1.75%)

After-hours: Nov 13, 2026, 7:30 PM EST

Cellectar Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.58	13.2	23.29	9.56	19.87	35.7
Cash & Short-Term Investments	24.58	13.2	23.29	9.56	19.87	35.7
Cash Growth	95.81%	-43.34%	143.48%	-51.85%	-44.36%	-37.54%
Prepaid Expenses	1.13	0.84	0.96	0.89	0.66	0.87
Total Current Assets	25.71	14.04	24.25	10.45	20.53	36.57
Property, Plant & Equipment	1.65	0.91	1.19	1.59	0.98	0.55
Other Long-Term Assets	2.38	0.03	0.03	0.03	0.08	0.08
Total Assets	29.74	14.98	25.47	12.08	21.59	37.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.73	1.44	4.11	9.18	2.56	1.41
Accrued Expenses	-	2.48	2.17	-	2.91	2.44
Current Portion of Leases	0	0.1	0.08	0.06	0.05	0.14
Other Current Liabilities	0.07	0.73	3.03	16.12	5.98	-
Total Current Liabilities	5.8	4.75	9.39	25.36	11.5	3.99
Long-Term Leases	1.53	0.31	0.41	0.49	0.55	0.17
Total Liabilities	7.33	5.06	9.8	25.85	12.05	4.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	312.11	277.15	261.12	182.92	168.14	182.56
Retained Earnings	-289.69	-269.13	-247.34	-202.76	-159.99	-150.9
Total Common Equity	22.42	8.02	13.77	-19.84	8.15	31.66
Shareholders' Equity	22.42	9.92	15.68	-13.78	9.54	33.05
Total Liabilities & Equity	29.74	14.98	25.47	12.08	21.59	37.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.53	0.41	0.49	0.55	0.6	0.3
Net Cash (Debt)	23.05	12.79	22.79	9.01	19.26	35.4
Net Cash Growth	90.15%	-43.91%	152.94%	-53.22%	-45.59%	-37.61%
Net Cash Per Share	2.41	4.90	18.41	22.12	81.90	191.31
Filing Date Shares Outstanding	10.04	4.24	1.54	1.08	0.32	0.2
Total Common Shares Outstanding	10.04	4.24	1.54	0.69	0.31	0.2
Working Capital	19.92	9.29	14.86	-14.91	9.03	32.58
Book Value Per Share	2.23	1.89	8.97	-28.69	26.06	155.46
Tangible Book Value	22.42	8.02	13.77	-19.84	8.15	31.66
Tangible Book Value Per Share	2.23	1.89	8.97	-28.69	26.06	155.46
Machinery	-	-	-	-	0.8	0.58
Leasehold Improvements	-	-	-	-	0.31	0.31

SEC Filings: 10-K · 10-Q